The effectiveness of long-acting injectable antipsychotics versus oral antipsychotics in the maintenance treatment of outpatients with chronic schizophrenia.
Su-Chen FangDing-Lieh LiaoCheng-Yi HuangChun-Chi HsuShu-Li ChengYu-Hsuan Joni ShaoPublished in: Human psychopharmacology (2020)
Chronic schizophrenia patients who received only LAIs had a lower risk of disease relapse and a reduction in psychiatric service utilization than those receiving only OAPs.